Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45)
- 1 July 2000
- journal article
- clinical trial
- Published by Wiley in Diabetic Medicine
- Vol. 17 (7) , 518-523
- https://doi.org/10.1046/j.1464-5491.2000.00320.x
Abstract
SUMMARY Aims To assess the effect of diet on fasting plasma lipids and lipoproteins in patients with newly diagnosed Type 2 diabetes.Methods A total of 2906 patients each underwent 3 months' diet therapy before allocation to therapy in a randomized controlled clinical trial. Lipids and lipoproteins were measured at diagnosis and after 3 months' diet.Results The mean body weight at diagnosis was 83 kg. Weight decreased after diet by a mean of 4.5 kg; body mass index (BMI) decreased by 1.51 kg/m2; plasma glucose fell by 3 mmol/l from 11 mmol/l; and HbA1c by 2% from 9%. Triglyceride concentrations were reduced in men by −0.41 (95% confidence interval (CI) −0.47 to − 0.35) mmol/l from a geometric mean 1.8 (1 sd interval 1.0–3.0) mmol/l, and in women by −0.23 (−0.28 to −0.18) mmol/l from a similar level. Cholesterol decreased in men by −0.28 (−0.33 to −0.24) mmol/l from 5.5 (1.1) mmol/l, and in women by −0.09 (−0.14 to −0.04) mmol/l from 5.8 (1.2) mmol/l with corresponding changes in LDL cholesterol. HDL cholesterol increased in men by 0.02 (0.01 to 0.04) mmol/l and in women by 0.01 (0 to 0.02) mmol/l. Triglyceride concentration in the top tertile was reduced by 37% in men (> 2.1 mmol/l) and by 23% in women (> 2.2 mmol/l) with regression to mean accounting for 13% and 6%, respectively. Similarly cholesterol in the top tertile was reduced by 12% in men (> 5.8 mmol/l) and 7% in women (> 6.2 mmol/l) with 6% of the decrease in both men and women accounted for by regression to the mean.Conclusions Initial dietary therapy in patients with newly diagnosed Type 2 diabetes substantially reduced plasma triglyceride, marginally improved total cholesterol and subfractions, and resulted in a potentially less atherogenic profile, although this did not eliminate the excess cardiovascular risk in patients with Type 2 diabetes.Keywords
This publication has 34 references indexed in Scilit:
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Dietary Fat Intake and the Risk of Coronary Heart Disease in WomenNew England Journal of Medicine, 1997
- U.K. Prospective Diabetes Study 27: Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sexDiabetes Care, 1997
- How to deal with regression to the mean in intervention studiesThe Lancet, 1996
- UK Prospective Diabetes Study XII: Differences Between Asian, Afro‐Caribbean and White Caucasian Type 2 Diabetic Patients at Diagnosis of DiabetesDiabetic Medicine, 1994
- UK Prospective Diabetes Study (UKPDS) XI: Biochemical Risk Factors in Type 2 Diabetic Patients at Diagnosis Compared with Age‐matched Normal SubjectsDiabetic Medicine, 1994
- Dietary Advice Based on the Glycaemic Index Improves Dietary Profile and Metabolic Control in Type 2 Diabetic PatientsDiabetic Medicine, 1994
- Dietary Recommendations for People with Diabetes: An Update for the 1990sDiabetic Medicine, 1992
- HETEROGENEITY OF MATURITY ONSET DIABETES AT YOUNG AGE (MODY)The Lancet, 1981